The government will set up 3,000 new generic medicine stores across the country to tackle the shortage of drugs in rural areas, Finance Minister Arun Jaitley said on Monday.
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
The government will set up 3,000 new generic medicine stores across the country to tackle the shortage of drugs in rural areas, Finance Minister Arun Jaitley said on Monday.
US researchers have found there is a relationship between prolonged stress and memory loss.The results of the study showed that those who were repeatedly exposed to stress had a trouble with spatial memory.
Low levels of vitamin D in men can predict aggressive prostate cancer identified at the time of surgery, new research has found.
An abortion drug, Mifepristone (MIF) can possibly have an anti-tumour effect in triple-negative breast cancer (TNBC), the media reported on Tuesday.
Opening a new window of opportunity for treating dementia, researchers have found that a drug compound created to treat cancer can restore memory in mice with Alzheimer's like disease.
Offering hope to millions of cancer patients around the world, the Scottish government has launched a new app that helps doctors diagnose the disease using information about symptoms, signs and images of what to look out for, a media report said.
US researchers have developed an inexpensive prototype of a biomedical device that can detect anaemia simply by running a blood sample from a finger prick under a smartphone.
Gum diseases are linked to many health problems. A type of bacterial species responsible for gum disease may also be a cause of esophageal cancer, finds a new study.
AstraZeneca announced it has entered into a licensing agreement with China Medical System Holdings Ltd (CMS) for the commercialisation rights in China to its calcium channel blocker, Plendil (felodipine). Plendil was first approved in China in 1995 for the treatment of hypertension or high blood pressure and in 2015 achieved Product Sales of $189 million.
Baxalta Incorporated announced that it has submitted supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] to treat children under the age of 12 with hemophilia A and for use in surgical settings.